Articles by Disease (Cancer Of Unknown Primary)

Induction of CYP1A1. The AhR / DRE Paradigm Transcription, Receptor Regulation, and Expanding Biological Roles

Journal: Current Drug Metabolism
Volume: 2
Page: 149-164
Author(s): Qiang Ma

Hepatic Cytochrome P450 Regulation in Disease States

Journal: Current Drug Metabolism
Volume: 2
Page: 165-183
Author(s): Po-Yung Cheng and Edward T. Morgan

Update on Antifolate Drugs Targets

Journal: Current Drug Targets
Volume: 2
Page: 135-166
Author(s): M. P. Costi and S. Ferrari

Immunomodulating Anticancer Alkylating Drugs: Targets and Mechanisms of Activity

Journal: Current Drug Targets
Volume: 2
Page: 197-212
Author(s): S. Ben-Efraim

Revisiting proteus: Do Minor Changes in Lectin Structure Matter in Biological Activity? Lessons from and Potential Biotechnological Uses of the Diocleinae Subtribe Lectins

Journal: Current Protein & Peptide Science
Volume: 2
Page: 123-135
Author(s): B. S. Cavada, T. Barbosa, S. Arruda, T. B. Grangeiro and M. Barral-Netto

Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption.

Journal: Current Pharmaceutical Design
Volume: 7
Page: 613-635
Author(s): Paul J. Kostenuik and victoria Shalhoub

Molecular Mechanisms of Thiamine Utilization.

Journal: Current Molecular Medicine
Volume: 1
Page: 197-207
Author(s): Charles K. Singleton. and Peter R. Martin

Multidrug Efflux in Pseudomonas aeruginosa Components, Mechanisms and Clinical Significance

Journal: Current Topics in Medicinal Chemistry
Volume: 1
Page: 59-71
Author(s): Keith Poole and Ramakrishnan Srikumar

An Approach to the Rational Design of Opioid Receptor Ligands Non-narcotic k-Opioid Receptor Ligand KT-95 Free from Euphoria and or Dysphoria

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 1
Page: 1-25
Author(s): Ken Kanematsu and Takeshi Sagara

Carbonic Anhydrase Inhibitors

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 1
Page: 61-97
Author(s): Claudiu T. Supuran and Andrea Scozzafava